Emcure Pharma Q2 FY27 profit surge and record stock gains

Statements (10 of 15)

1. ▲ Bullish

   Emcure Pharma reported a 29.31% increase in consolidated net profit to ₹325.06 crore during the September quarter

   thehindubusinessline.comNov 4, 2026 04:56 UTCHigh importance
2. ▲ Bullish

   Emcure Pharma stock hit a new high after analysts at Jefferies raised their price target.

   business-standard.comNov 4, 2026 04:38 UTC
3. ▲ Bullish

   Emcure Pharma raised its full-year growth guidance following strong Q2 FY27 results

   economictimes.indiatimes.comNov 4, 2026 04:31 UTCHigh importance
4. ▲ Bullish

   Emcure Pharmaceuticals reported profit increased 29% and revenue grew 24% in Q2FY27.

   livemint.comNov 4, 2026 04:17 UTCHigh importance
5. ▲ Bullish

   Emcure Pharmaceuticals shares rose 16% in two trading sessions, reaching a record high.

   livemint.comNov 4, 2026 04:17 UTCHigh importance
6. ▲ Bullish

   Kotak Securities raised its price target for Emcure Pharmaceuticals to ₹2,450.

   livemint.comNov 4, 2026 04:17 UTC
7. ▲ Bullish

   Emcure Pharmaceuticals posted a consolidated net profit of Rs 325.06 crore for the September quarter.

   economictimes.indiatimes.comNov 3, 2026 13:13 UTCHigh importance
8. ▲ Bullish

   Emcure Pharma recorded a 34% growth in international business to ₹1,665.2 crore during the quarter

   business-standard.comNov 3, 2026 11:36 UTCHigh importance
9. ▲ Bullish

   Emcure Pharma's net profit rose 29.31% to ₹325 crore in Q2FY27

   business-standard.comNov 3, 2026 11:36 UTCHigh importance
10. ▲ Bullish

    Emcure Pharma reported EBITDA of ₹587.3 crore for the quarter, a 23.5% increase from the prior year.

    cnbctv18.comNov 3, 2026 09:04 UTC

5 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=135d8817-c96b-4a0e-8eae-35aded799b95 Get a free API key ↗